VACCINEX INC
For the period ended Dec 31, 2023. Filed Apr 2, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 2, 2024
VCNX$1.41-61.4%Stored close · as of Dec 17, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2023 and 2022
Balance Sheets
(in thousands, except share and per share data)
| As of December 31, 2023 | As of December 31, 2022 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,535 | $6,391 |
| Accounts receivable | 961 | 175 |
| Prepaid expenses and other current assets | 853 | 912 |
| Total current assets | 3,349 | 7,478 |
| Property and equipment, net | 136 | 189 |
| Operating lease right-of-use asset | 146 | 310 |
| TOTAL ASSETS | $3,631 | $7,977 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,039 | $1,518 |
| Accrued expenses | 1,242 | 781 |
| Deferred revenue | 63 | - |
| Current portion of long-term debt | 75 | 74 |
| Operating lease liability | 146 | 164 |
| Warrant liability | 2,351 | - |
| Total current liabilities | 5,916 | 2,537 |
| Long-term debt | 26 | 101 |
| Operating lease liability, net of current portion | - | 146 |
| TOTAL LIABILITIES | 5,942 | 2,784 |
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity (deficit): | ||
| Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of December 31, 2023, and December 31, 2022; 892,622 and 237,532 shares issued as of December 31, 2023 and December 31, 2022, respectively; 892,617 and 237,527 shares outstanding as of December 31, 2023 and December 31, 2022, respectively | - | - |
| Additional paid-in capital | 337,627 | 324,880 |
| Treasury stock, at cost; 5 shares of common stock as of December 31, 2023 and December 31, 2022, respectively | (11) | (11) |
| Accumulated deficit | (339,927) | (319,676) |
| TOTAL STOCKHOLDERS’ EQUITY/(DEFICIT) | (2,311) | 5,193 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $3,631 | $7,977 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.